Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: Influence of methimazole treatment

被引:0
|
作者
Werner, MC
Rosa, LFBPC
Romaldini, JH
Curi, R
机构
[1] UNIV SAO PAULO, INST BIOMED SCI, DEPT PHYSIOL & BIOPHYS, SAO PAULO, SP, BRAZIL
[2] HOSP SERVIDOR PUBL ESTADUL, IAMSPE, DEPT ENDOCRINOL, SAO PAULO, SP, BRAZIL
关键词
Graves' disease; methimazole; thyroid hormones; glucose; glutamine; immune function; lymphocytes;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several studies have shown that thyroid hormones are able to influence selected immune responses such as cell mediated immunity, differentiation of B lymphocytes and the activity of NK cells. These hormones can also regulate the metabolism of glucose and glutamine in rat macrophages and their effects seem to occur mainly through the Krebs cycle. Alterations in the hexokinase, citrate synthase, glucose-6-phosphate dehydrogenase and glutaminase activities in lymphocytes from patients with Graves' disease, either untreated or on methimazole (MMI) therapy were investigated. Experiments were also done in vitro to determine the activities of these enzymes in normal lymphocytes cultured for 24h in the presence of MMI, T-3 and T-4 using concentrations close to the physiological. Changes in the conversion of [U-C-14]-glucose and [U-C-14]-glutamine to (CO2)-C-14 as caused by the addition of MMI, T-3 or T-4 to the culture medium were also evaluated. The results indicate that high levels of thyroid hormones might stimulate the metabolism of glucose and glutamine for a short period of time but, if the stimulus is maintained, the utilization of glutamine by lymphocytes is then suppressed. Moreover, MMI does affect lymphocyte metabolism but the significance of this finding for its immunosuppressive effect remains to be examined.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [31] Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: A retrospective study
    Mazza, E.
    Carlini, M.
    Flecchia, D.
    Blatto, A.
    Zuccarini, O.
    Gamba, S.
    Beninati, S.
    Messina, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (10) : 866 - 872
  • [32] Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment
    Gallo, Daniela
    Bruno, Antonino
    Gallazzi, Matteo
    Cattaneo, Simona Antonia Maria
    Veronesi, Giovanni
    Genoni, Angelo
    Tanda, Maria Laura
    Bartalena, Luigi
    Passi, Alberto
    Piantanida, Eliana
    Mortara, Lorenzo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [33] Neutropenia Occurs More Often Under Carbimazole than Under Methimazole Treatment in Pediatric Graves' Disease Patients
    Schempp, Vera
    Cebeci, Ayse Nurcan
    Reinauer, Christina
    Woelfle, Joachim
    Doerr, Helmuth-Guenther
    Roosen, Marie-Therese
    Gohlke, Jonas
    Gohlke, Bettina
    THYROID, 2024, 34 (06) : 735 - 743
  • [34] HETEROGENEITY OF THYROTROPIN BINDING INHIBITOR IMMUNOGLOBULINS IN SERUM FROM UNTREATED PATIENTS WITH HYPERTHYROID GRAVES-DISEASE
    LU, C
    KASAGI, K
    IIDA, Y
    KONISHI, J
    IMMUNOLOGY LETTERS, 1991, 28 (03) : 233 - 236
  • [35] Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis
    Junker, Anders E.
    Gluud, Lise L.
    Holst, Jens J.
    Knop, Filip K.
    Vilsboll, Tina
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (10) : 1522 - 1528
  • [36] The influence of thiamazole, lithium carbonate, or prednisone administration on the efficacy of radioiodine treatment (131I) in hyperthyroid patients
    Oszukowska, Lidia
    Knapska-Kucharska, Malgorzata
    Makarewicz, Jacek
    Lewinski, Andrzej
    ENDOKRYNOLOGIA POLSKA, 2010, 61 (01) : 56 - 61
  • [37] A 6-year Follow-up of a Randomized Prospective Trial Comparing Methimazole Treatment with or without Exogenous L-thyroxine in Chinese Patients with Graves' Disease
    Liu, X.
    Qiang, W.
    Liu, X.
    Liu, L.
    Liu, S.
    Gao, A.
    Gao, S.
    Shi, B.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (10) : 564 - 567
  • [38] EFFECTS OF METHIMAZOLE AND PROPYLTHIOURACIL ON GLUCOSE AND LIPID METABOLISM, SERUM THYROXINE, CYSTATIN C AND B2-MICROGLOBULIN IN PATIENTS WITH HYPERTHYROIDISM
    Luo, Yuting
    Zhang, Juan
    Luo, Jie
    Li, Yong
    ACTA MEDICA MEDITERRANEA, 2019, 35 (06): : 3035 - 3039
  • [39] Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves' disease patients with thyrotoxic periodic paralysis
    Karndumri, Krittadhee
    Thewjitcharoen, Yotsapon
    Chatchomchuan, Waralee
    Porramatikul, Sriurai
    Krittiyawong, Sirinate
    Wanothayaroj, Ekgaluck
    Butadej, Siriwan
    Nakasatien, Soontaree
    Rajatanavin, Rajata
    Himathongkam, Thep
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2020, 21
  • [40] Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment
    Miettinen, Tatu A.
    Gylling, Helena
    CLINICA CHIMICA ACTA, 2007, 379 (1-2) : 53 - 58